The team that wrote the paper are the team that Optiscan is...

The team that wrote the paper are the team that Optiscan is working with for the study being conducted by the University of Adelaide Dental School.

From the last quarterly

"During the Quarter, Australia’s 2nd highest ranked dental school, the University of Adelaide Dental School,
received final approval for its “Proof of Concept Study: A diagnostic tool to detect Oral Squamous Cell
Carcinoma”. This 30 patient ex vivo study will use Optiscan’s FIVE2 (ViewnVivo) system for applications in
relation to oral and oropharyngeal cancer. Use of Optiscan’s technology by another leading Australian dental
school will be an important validation of its efficacy and utility as Optiscan moves closer to approval and
commercialisation of its clinical device. Following the end of the Quarter, a system has been sent to the Adelaide
Dental School for the conduct of the study"

The papers using Cellvizio were written 2014 - 2016 and nothing since then.
The InVivage device offers handpiece controls,Z stacking,reusable sheath and better image to list a few advantages over Cellvizio.

Also from the last quarterly hat hasn`t received any comment here

"Discussions took place with a leading Melbourne based oral surgeon regarding the commencement of an oral
cancer surgical clinical trial at one of Melbourne’s most highly regarded hospitals and are expected to be
advanced following the lifting of COVID restrictions."

I don`t think it would be unreasonable to expect some progress on the above during the December Qtr leading to another
trial in oral cancer

"Maintain the rage"!!